Metabolic Phenotypes of Obesity and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
1. Comparison between the 4 groups of metabolic phenotypes of obesity as regard the presence and frequency of DKD 2. Relation between DKD , obesity (BMI) and metabolic risk factors in patients with type 2 DM
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Type 2 diabetic adult patients admitted at Assiut university hospital divided into 4 groups of metabolic phenotypes according to obesity and metabolic status .
Disqualifiers
Age less than 18
type 1 diabetes
those with a BMI <18.5 kg/m2
co-existing non-diabetic renal disease
Trial population
Type 2 diabetic adult patients admitted at Assiut university hospital
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
24 hour urinary protein
Diagnostic testproteinuria and renal function impairment will be detected in patients of four groups
Treatment groups
71 Participants
are divided into 4 treatment groupsGroup A: metabolically healthy non obesity (MHNO)1 intervention
Group B: metabolically healthy obesity ( MHO )1 intervention
Group C: metabolically unhealthy non obsesity ( MUNO )1 intervention
Group D: metabolically unhealthy obesity ( MUO )1 intervention
Trial outcomes
Primary outcomes
1
Conclusion of the relationship between metabolic phenotypes of obesity and Diabetic kidney disease in type 2 diabetes Mellitus patients
conclusion the relation between metabolic phenotypes of obesity and diabetic kidney disease in type 2 diabetes mellitus patients
Time frame
BaselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: